Benitec Biopharma's (BNIKF) CEO Greg West on Q1 2017 Results - Earnings Call Transcript [Seeking Alpha]
Benitec Biopharma Inc. (BNTC)
US:NASDAQ Investor Relations:
benitec.com/for-investors/investor-faqs
Company Research
Source: Seeking Alpha
Start Time: 18:00 End Time: 18:35 Benitec Biopharma Ltd ( OTCPK:BNIKF ) Q1 2017 Earnings Conference Call May 30, 2017, 18:00 PM ET Executives Greg West - CEO David Suhy - CSO Cliff Holloway - Chief Business and Operations Officer Georgina Kilfoil - Chief Clinical and Development Operations Officer Analysts Marc Sinatra - Lodge Partners Jason McCarthy - Maxim Group Operator Thank you for standing by and welcome to the Benitec Biopharma Quarterly Corporate Update Conference Call. If we make any forward-looking statements, we note that such statements involve risks and uncertainties relating to the difficulties in our plans to develop and commercialize our product candidates, the timing of the initiation and completion of preclinical and clinical trials, the timing of patient enrollments and dosing in clinical trials, the timing of expected regulatory filings, the clinical utility and potential attributes and benefits of the ddRNAi and our product ca
Show less
Read more
Impact Snapshot
Event Time:
BNTC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BNTC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BNTC alerts
High impacting Benitec Biopharma Inc. news events
Weekly update
A roundup of the hottest topics
BNTC
News
- Benitec Biopharma Inc. (NASDAQ: BNTC) had its price target raised by analysts at JMP Securities from $10.00 to $16.00. They now have a "market outperform" rating on the stock.MarketBeat
- Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with BB-301 in Phase 1b/2a Study [Yahoo! Finance]Yahoo! Finance
- Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with BB-301 in Phase 1b/2a StudyGlobeNewswire
- Benitec Biopharma Announces Oversubscribed Private Placement Financing of $40.0 Million [Yahoo! Finance]Yahoo! Finance
- Benitec Biopharma Announces Oversubscribed Private Placement Financing of $40.0 MillionGlobeNewswire
BNTC
Sec Filings
- 4/25/24 - Form D
- 4/19/24 - Form 8-K
- 4/18/24 - Form 8-K
- BNTC's page on the SEC website